MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation Total Liabilities 2011-2026 | EW
Annual Total Liabilities Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.36 B | 2.99 B | 2.64 B | 2.49 B | 2.67 B | 2.66 B | 2.34 B | 2.18 B | 2.74 B | 1.89 B | 1.56 B | 1.33 B | 1.17 B | 742 M | 643 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.36 B | 643 M | 2.09 B |
Quarterly Total Liabilities Edwards Lifesciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.07 B | 2.88 B | 2.83 B | 2.99 B | 3.36 B | 2.59 B | 2.55 B | 2.64 B | 2.64 B | 2.56 B | 2.59 B | 2.49 B | 2.42 B | - | 2.58 B | 2.67 B | 2.62 B | - | - | 2.66 B | 2.66 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.36 B | 2.42 B | 2.71 B |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Align Technology
ALGN
|
2.36 B | $ 164.69 | -7.13 % | $ 12.3 B | USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
Sintx Technologies
SINT
|
6.58 M | $ 2.32 | -4.13 % | $ 6.43 M | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Sensus Healthcare
SRTS
|
4.94 M | $ 3.8 | -5.24 % | $ 62 M | USA |
 |
Stryker Corporation
SYK
|
25.4 B | $ 328.87 | -1.15 % | $ 126 B | USA |
 |
Alphatec Holdings
ATEC
|
126 M | $ 10.95 | -4.99 % | $ 1.64 B | USA |
 |
Tactile Systems Technology
TCMD
|
55 M | $ 26.55 | -0.86 % | $ 607 M | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
TELA Bio
TELA
|
75.1 M | $ 0.66 | -11.27 % | $ 31 M | USA |
 |
Abbott Laboratories
ABT
|
36.6 B | $ 105.12 | 0.53 % | $ 183 B | USA |
 |
Tandem Diabetes Care
TNDM
|
726 M | $ 21.37 | -8.36 % | $ 1.45 B | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 69.36 | -1.15 % | $ 103 B | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 35.31 | -3.63 % | $ 1.1 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
3 M | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Viemed Healthcare
VMD
|
55.6 M | $ 9.26 | 0.43 % | $ 360 M | USA |
 |
Cytosorbents Corporation
CTSO
|
36.3 M | $ 0.59 | -1.05 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
2.24 M | $ 2.19 | -3.52 % | $ 3.42 M | USA |
 |
Varex Imaging Corporation
VREX
|
621 M | $ 10.81 | 0.23 % | $ 448 M | USA |
 |
Vivos Therapeutics
VVOS
|
7.33 M | $ 1.13 | -5.04 % | $ 5.67 M | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Beyond Air
XAIR
|
15.7 M | $ 0.69 | -0.72 % | $ 46.7 M | USA |
 |
Xtant Medical Holdings
XTNT
|
50.9 M | $ 0.57 | 0.51 % | $ 76.2 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
8.89 B | $ 88.4 | -0.85 % | $ 18 B | USA |
 |
AdaptHealth Corp.
AHCO
|
2.79 B | $ 11.24 | -1.49 % | $ 1.52 B | USA |
 |
Penumbra
PEN
|
399 M | $ 335.31 | -0.33 % | $ 13 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 15.72 | -3.85 % | $ 369 M | USA |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
7.58 M | - | 10.0 % | $ 610 K | USA |
 |
IRIDEX Corporation
IRIX
|
24.9 M | - | - | $ 16 M | USA |